Comment

. 2021 May;6(5):336-337.

doi: 10.1016/S2468-1253(21)00063-7. Epub 2021 Mar 19.

Prevention of post-ERCP pancreatitis: the search continues

Jeffrey J Easler¹, Evan L Fogel²

Affiliations

¹ Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Electronic address: jjeasler@iu.edu.
² Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

PMID: 33740414
PMCID: PMC8116937
DOI: 10.1016/S2468-1253(21)00063-7

Comment

Prevention of post-ERCP pancreatitis: the search continues

Jeffrey J Easler et al. Lancet Gastroenterol Hepatol. 2021 May.

. 2021 May;6(5):336-337.

doi: 10.1016/S2468-1253(21)00063-7. Epub 2021 Mar 19.

Authors

Jeffrey J Easler¹, Evan L Fogel²

Affiliations

¹ Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Electronic address: jjeasler@iu.edu.
² Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

PMID: 33740414
PMCID: PMC8116937
DOI: 10.1016/S2468-1253(21)00063-7

No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial.
Sperna Weiland CJ, Smeets XJNM, Kievit W, Verdonk RC, Poen AC, Bhalla A, Venneman NG, Witteman BJM, da Costa DW, van Eijck BC, Schwartz MP, Römkens TEH, Vrolijk JM, Hadithi M, Voorburg AMCJ, Baak LC, Thijs WJ, van Wanrooij RL, Tan ACITL, Seerden TCJ, Keulemans YCA, de Wijkerslooth TR, van de Vrie W, van der Schaar P, van Dijk SM, Hallensleben NDL, Sperna Weiland RL, Timmerhuis HC, Umans DS, van Hooft JE, van Goor H, van Santvoort HC, Besselink MG, Bruno MJ, Fockens P, Drenth JPH, van Geenen EJM; Dutch Pancreatitis Study Group. Sperna Weiland CJ, et al. Lancet Gastroenterol Hepatol. 2021 May;6(5):350-358. doi: 10.1016/S2468-1253(21)00057-1. Epub 2021 Mar 19. Lancet Gastroenterol Hepatol. 2021. PMID: 33740415 Clinical Trial.

Cited by

Does patient's position count during Endoscopic Retrograde Cholangio-pancreatography? Left lateral decubitus versus prone position.
Alam L, Khan RSA, Saeed F, Sher F, Khan RZA. Alam L, et al. Pak J Med Sci. 2023 Sep-Oct;39(5):1232-1237. doi: 10.12669/pjms.39.5.6932. Pak J Med Sci. 2023. PMID: 37680842 Free PMC article.
Early versus late pancreatic stent placement for preventing post-ERCP pancreatitis: protocol of a multicenter randomized clinical trial.
Wang S, Bai B, Hong J, Xu W, Shen Z, Xue Y, Zhang Y, Li M, Huang Q, Zhang W, Jie L, Shi C, Hu C, Wang B, Ding H, Li S, Li D, Lu Q, Li Y, Liu X, Hong R, Mei Q, Bao J. Wang S, et al. Trials. 2025 Jun 4;26(1):189. doi: 10.1186/s13063-025-08878-8. Trials. 2025. PMID: 40462140 Free PMC article.
Endoscopic retrograde cholangiopancreatography outcomes in inflammatory bowel disease patients: a 12-year analysis of a national database.
Deshmukh A, Desai PM, Chrusciel T, Nwankwo E, Tripathi R, Cheesman AR. Deshmukh A, et al. Int J Colorectal Dis. 2023 May 19;38(1):137. doi: 10.1007/s00384-023-04427-4. Int J Colorectal Dis. 2023. PMID: 37204502

References

1. Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2020; 52: 127–49. - PubMed
1. Chandrasekhara V, Khashab MA, Muthusamy VR, et al. Adverse events associated with ERCP. Gastrointest Endosc 2017; 85: 32–47. - PubMed
1. Pekgoz M Post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review for prevention and treatment. World J Gastroenterol 2019; 25: 4019–42. - PMC - PubMed
1. Radadiya D, Devani K, Arora S, et al. Peri-procedural aggressive hydration for post endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis prophylaxsis: meta-analysis of randomized controlled trials. Pancreatology 2019; 19: 819–27. - PubMed
1. Sperna Weiland CJ, Smeets XJNM, Kievit W, et al. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial. Lancet Gastroenterol Hepatol 2021; published online March 16, 10.1016/S2468-1253(21)00057-1. - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

U01 DK127382/DK/NIDDK NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Prevention of post-ERCP pancreatitis: the search continues

Affiliations

Prevention of post-ERCP pancreatitis: the search continues

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical